The global bioanalytical testing services market is projected to reach USD 3.7 billion by 2025 from USD 2.1 billion in 2020, at a CAGR of 11.8%

    NEXT STORY
    UK Fears Cybercriminals Will Use NHSX COVID-19 Tracing App to Launch Cyber Attacks
    PREV STORY
    Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Precision Therapeutics, Inc. Signs Letter of Intent to Purchase Remainder of Helomics Corporation Shares

    author_avatar
    NASDAQ Market News

    Generex Participating on Expert Panel for Fierce Pharma & Fierce Healthcare Corona Virus Virtual Series

    author_avatar
    NASDAQ Market News

    Athersys Announces Expansion of Collaboration With Healios

    Healios receives rights to develop and commercialize additional indications and Athersys receives $20 million ...

    author_avatar
    NASDAQ Market News